Epidemic hemorrhagic fever(Hemorrhagic fever with renal syndrome)
Conditions
Interventions
Experimental group:Western medicine basic treatment combined with "Qingyi No. 4 granule"
Placebo group:Western medicine basic treatment combined with "Qingyi No. 4 placebo"
Sponsors
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Comply with the diagnostic criteria for epidemic hemorrhagic fever; (2) hypotension shock and/or renal failure oliguria (greater than 5 days) in the acute phase; (3) Currently entering the epidemic hemorrhagic fever polyuria period: 24h urine volume > 2000ml; (4) Comply with the diagnostic criteria of TCM syndrome (syndrome of lingering pathogen due to deficient vital qi); (5) The age range is between 18 and 70 years old; (6) Voluntarily accept the treatment plan and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) an overdue patient who has not experienced a shock/oliguria; (2) Patients with abnormal liver function (ASK, ALT exceeds the upper limit of 1.5 times); (3) Those who cannot take Chinese medicine due to diseases such as gastrointestinal bleeding; (4) Combine severe heart, cerebrovascular and liver, kidney, hematopoietic diseases, and mental patients; (5) Oral treatment with Chinese medicine within 4 weeks; (6) Pregnant, pregnant or lactating women; (7) With history of allergic reactions to related drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recovery period (recovery time for kidney damage, blood pressure and anemia); | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM symptom score; | — |
Countries
China
Contacts
Public ContactZheng Peiyong
Outcome results
None listed